CIK 0001837607 · <br>Emerging growth company
AEON Biopharma, Inc.
Sign in to watch- Ticker
- AEON
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 853940478
- Phone
- (949) 354-6499
- Business address
- 130 VANTIS DRIVE, SUITE 170, ALISO VIEJO, CA, 92656
- Former names
- Priveterra Acquisition Corp.
- Open-market buys, last 90 days
- $243,455
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$243,455. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-31 | Sy Jennifer PRINCIPAL ACCOUNTING OFFICER | Grant or award · Stock Option | +48,063 | 48,063 | ||
| 2024-08-31 | Carter Eric G Director | Grant or award | +36,021 | 36,021 | ||
| 2024-08-31 | Carter Eric G Director | Grant or award · Stock Option | +96,210 | 96,210 | ||
| 2024-08-31 | Thunen Shelley B Director | Grant or award | +36,021 | 36,021 | ||
| 2024-08-31 | Thunen Shelley B Director | Grant or award · Stock Option | +96,210 | 96,210 | ||
| 2024-08-31 | PALMISANO ROBERT J Director | Grant or award | +36,021 | 36,021 | ||
| 2024-08-31 | PALMISANO ROBERT J Director | Grant or award · Stock Option | +96,210 | 96,210 | ||
| 2024-04-12 | Daewoong Co., Ltd 10% owner | Other acquisition · Senior Secured Convertible Note | +0 | |||
| 2024-04-11 | Daewoong Co., Ltd 10% owner | Other acquisition · Senior Secured Convertible Note | +0 | |||
| 2024-03-24 | Daewoong Co., Ltd 10% owner | Other acquisition · Senior Secured Convertible Note | +0 | |||
| 2024-03-19 | Thunen Shelley B Director | Grant or award · Stock Option | +16,260 | 16,260 | ||
| 2024-03-19 | PALMISANO ROBERT J Director | Grant or award · Stock Option | +16,260 | 16,260 | ||
| 2024-03-19 | Forth Marc CHIEF EXECTUIVE OFFICER | Grant or award · Stock Option | +212,466 | 212,466 | ||
| 2024-03-19 | Oh Chad CHIEF MEDICAL OFFICER | Grant or award · Stock Option | +86,720 | 86,720 | ||
| 2024-03-19 | FISCHER JOST Director | Grant or award · Stock Option | +16,260 | 16,260 | ||
| 2024-03-19 | Carter Eric G Director | Grant or award · Stock Option | +16,260 | 16,260 | ||
| 2024-03-19 | Carter Eric G Director | Grant or award · Stock Option | +8,130 | 8,130 | ||
| 2024-03-19 | Wilson Alexander Blair EXEC VP, CLO & CORP SECRETARY | Grant or award · Stock Option | +81,300 | 81,300 | ||
| 2023-08-14 | Thunen Shelley B Director | Grant or award · Stock Option | +58,851 | 58,851 | ||
| 2023-08-14 | PALMISANO ROBERT J Director | Grant or award · Stock Option | +58,851 | 58,851 |
Page 3 of 5 · 97 trades